PDB18 COMPARISON OF RESOURCES UTILIZATION (RU)AND COST IN DRUG NAVE TYPE 2 DIABETES (T2D) PATIENTS TREATED WITH ROSIGLITAZONE (RSG)VS. SULFONYLUREA (SU) MONOTHERAPY
Abstract
Authors
MS Duh A Gosselin N Beaulieu LM Arana B Arondekar